Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. PRFX.NASDAQ

Painreform Ltd (PRFX NASDAQ) stock market data APIs

$0.38 -0.03(-7.3%) as of July 26, 2024
Price chart is built with Anychart

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.

Painreform Ltd Financial Data Overview

0.4128
0.38
-
0.4184
0.38
0.379-8.59
1 325 K
3 468 K
0
-2.72
0.607
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PRFX',
Type: 'Common Stock',
Name: 'Painreform Ltd',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00VT0S8T0',
ISIN: 'IL0011651580',
CUSIP: NULL,
CIK: '1801834',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-09-01',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Painreform Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -12 716 000
  • Earnings Per Share -7.74
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Painreform Ltd Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -2.4

Get Painreform Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Painreform Ltd latest news via APIs

PainReform Provides Business Update for the Third Quarter of 2023

TEL AVIV, Israel, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:PRFX
  • PAINREFORM LTD

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File

Targeting to commence second part of Phase 3 clinical trial in mid-Q4 2023 Trial completion and results expected in mid-2024 TEL AVIV, Israel, Sept. 11, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (N...
  • CLINICAL STUDY
  • NASDAQ:PRFX
  • PAINREFORM LTD
Do you have any questions?
support@eodhistoricaldata.com